Metformin for the Treatment of Diabetes in Pregnancy
1 other identifier
interventional
200
1 country
1
Brief Summary
The purpose of this study is to determine whether metformin is effective and safe in the treatment of diabetes in pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2006
CompletedFirst Posted
Study publicly available on registry
December 21, 2006
CompletedStudy Start
First participant enrolled
January 1, 2007
CompletedDecember 21, 2006
December 1, 2006
December 20, 2006
December 20, 2006
Conditions
Outcome Measures
Primary Outcomes (2)
glycemic control
pregnancy complications
Interventions
Eligibility Criteria
You may qualify if:
- pregnant women
- GDM A2
- diabetes mellitus type 2
- singleton pregnancy
You may not qualify if:
- diabetic nephropathy or proliferative retinopathy
- cannot swallow tablets
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Division of Obstetrics and Gynecology, Soroka University Medical Center
Beersheba, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Boaz Sheizaf, MD
division of obstetrics and gynecology, soroka university medical center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 20, 2006
First Posted
December 21, 2006
Study Start
January 1, 2007
Last Updated
December 21, 2006
Record last verified: 2006-12